Chimeric Primers Reduce Primer Dimer Formation in Multiplex PCR

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current PCR methods, particularly multiplex PCR, face inefficiencies due to non-specific amplification products like primer dimers, which divert resources away from target amplification and require significant time and effort to optimize, with existing methods lacking a general solution for primer design to mitigate this issue.

Innovation Solution

The use of chimeric primers comprising DNA and RNA bases, specifically designed to minimize or eliminate non-specific amplification by replacing adjacent DNA bases with RNA bases in strategic segments, reducing primer dimer formation without the need for iterative testing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional DNA primers are used in multiplex PCR, then the amplification reaction can proceed, but non-specific amplification products like primer dimers are formed which reduce efficiency

Engineering Contradiction:
Improveamplification efficiencyVSAvoidprimer dimer formation
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent applies local quality by modifying only specific positions within the primer sequence (positions 2-8 from the 5' end) while leaving the rest of the primer unchanged. The modification introduces a 5' phosphate group and alters nucleotides at specific locations to prevent primer-dimer formation, while maintaining the primer's ability to bind to the target sequence and enable efficient amplification.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes chemical parameters of the primer by introducing a 5' phosphate group and modifying nucleotides at specific positions. These parameter changes alter the primer's chemical properties to reduce non-specific binding and primer-dimer formation, while preserving its hybridization capability to the target sequence.

Inventive Principle:
Principle #35Parameter changes

2Object-generated harmful factors

If primer sequences are modified to reduce non-specific binding, then primer dimer formation decreases, but the design process becomes more complex

Engineering Contradiction:
Improvenon-specific amplificationVSAvoidprimer design complexity
Core Design Contradiction:
Object-generated harmful factorsVSDevice complexity

Solution Approach 1:

The patent segments the primer into distinct functional regions: a modified 5' end (positions 2-8) that prevents primer-dimer formation, and the remaining sequence that maintains target-specific binding. This segmentation allows independent optimization of each region's function, simplifying the overall design process.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies preliminary action by pre-modifying primers with a 5' phosphate group and specific nucleotide changes before PCR amplification. This preliminary modification prevents primer-dimer formation from the outset, eliminating the need for post-PCR cleanup steps and simplifying the overall workflow.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If extensive primer testing and optimization is performed, then assay specificity improves, but time and resources are significantly consumed

Engineering Contradiction:
Improveassay specificityVSAvoidoptimization time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by incorporating preventive modifications (5' phosphate group and specific nucleotide changes) into the primer design stage itself. This eliminates the need for extensive iterative testing and optimization, as the modifications preemptively prevent primer-dimer formation and ensure high assay specificity from the first run.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Chimeric primers effectively reduce primer dimer formation to less than 5-10% in multiplex PCR assays, enhancing amplification specificity and efficiency, and allowing for faster development and optimization of PCR assays with reduced costs and time.

Implementation Method 1

the specificity of primer hybridization and extension

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

the DNA polymerase extends primers based on these interactions

Methodology Applied
Scientific EffectPolymerization:

Data Source

PatentUS20230212559A1Chimeric primers and related methods
Publication Date: 2023.07.06 AGILENT TECHNOLOGIES INC
  • US20230212559A1 patent drawing
  • US20230212559A1 patent drawing
  • US20230212559A1 patent drawing

AI summary

The present disclosure provides chimeric primers suitable for use in the amplification of a nucleic acid sequence. In some aspects, these chimeric primers reduce the formation of primer dimers and/or off-target amplification products, compared to amplification reactions carried out using unmodified primers.